In March 2025, the company announced new options for any direct-to-client providing of its Wegovy weight loss drug. The company proven a brand new pharmacy, identified as NovoCare, which might cost consumers $499 every month for use of the drug, below 50 % the cost of the drug as a result of other pharmaceutical distribution networks.[fifty three]C